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Abstract
Background: Exposure to ambient air particulate matter (PM) has been linked to decline in pulmonary function
and cardiovascular events possibly through inflammation. Little is known about individual exposure to ultrafine
particles (UFP) inside and outside modern homes and associated health-related effects.
Methods: Associations between vascular and lung function, inflammation markers and exposure in terms of particle
number concentration (PNC; d = 10-300 nm) were studied in a cross-sectional design with personal and home indoor
monitoring in the Western Copenhagen Area, Denmark. During 48-h, PNC and PM2.5 were monitored in living rooms
of 60 homes with 81 non-smoking subjects (30-75 years old), 59 of whom carried personal monitors both when at
home and away from home. We measured lung function in terms of the FEV1/FVC ratio, microvascular function (MVF)
and pulse amplitude by digital artery tonometry, blood pressure and biomarkers of inflammation including C-reactive
protein, and leukocyte counts with subdivision in neutrophils, eosinophils, monocytes, and lymphocytes in blood.
Results: PNC from personal and stationary home monitoring showed weak correlation (r = 0.15, p = 0.24). Personal UFP
exposure away from home was significantly inversely associated with MVF (1.3% decline per interquartile range, 95%
confidence interval: 0.1-2.5%) and pulse amplitude and positively associated with leukocyte and neutrophil counts. The
leukocyte and neutrophil counts were also positively and pulse amplitude negatively associated with total personal
PNC. Indoor PNC and PM2.5 showed positive association with blood pressure and inverse association with eosinophil
counts.
Conclusions: The inverse association between personal exposure away from home and MVF is consistent with adverse
health effects of UFP from sources outside the home and might be related to increased inflammation indicated by
leukocyte counts, whereas UFP from sources in the home could have less effect.
Keywords: Indoor air pollution, Ambient air pollution, Ultrafine particles, Personal monitoring, Microvascular function,
Inflammation, Lung function
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Background
Deleterious effects of ambient air pollution and especially
particulate matter (PM) are documented by a large and
continuously growing number of studies [1-6]. PM con-
sists of a mixture of solid and liquid particles of organic
and inorganic origin suspended in the air, largely varying
in size, chemical composition, and toxicity due to continu-
ously undergoing multiple physical and chemical pro-
cesses [7]. Whereas the mass concentrations of PM with
diameter below 10 μm (PM10) and 2.5 μm (PM2.5) are
under regulation, there are currently no guideline values
for ultrafine particles (UFP) with diameter below 100 nm,
mostly formed during combustion processes, such as in
diesel engines or burning candles [7,8]. The UFP mass is
small compared to the larger particulate fractions and
UFP exposure is poorly represented by mass concentra-
tion, leaving particle number concentration (PNC) and
surface area as potentially more accurate defining metrics
emphasizing their hazardous nature [1,9]. The vast body
of epidemiological evidence on health effects of PM relies
on exposure assessment based on monitored or modeled
ambient levels of mainly PM10 and PM2.5 [1]. The UFP
levels in the studies that found association with health
outcomes show high spatial and temporal variation de-
monstrating the necessity of advanced exposure assess-
ment models [1].
Outdoor particles can infiltrate to indoor air through
open doors and windows, building ventilation system,
gaps and cracks in the building envelope [10-12]. In
addition, UFP and fine particles can also be released from
human activities occurring indoors. Combustion pro-
cesses, such as candle burning, cooking, smoking, working
space heaters, woodstoves, fireplaces, and gas stoves as
well as cleaning, use of house care products, and working
office equipment can substantially raise and further dom-
inate indoor particle levels [13-16]. Therefore, integrated
human exposure to UFP and fine particles is highly com-
plex as it encompasses exposure to particles from both
outdoor and indoor sources [8,17-19]. Considering that
people spend most of their time indoors, knowledge on
the relevance in terms of health effects for the particle ex-
posure occurring at home is important for targeted abate-
ment strategies.
Observations of short-term effects on vascular and
lung function as well as biomarkers of inflammation or
oxidative stress support epidemiological findings by de-
lineating mechanisms of actions of PM mediated health
effects [2,20-23]. Whereas a large number of studies
show negative association between ambient exposure to
traffic-related pollution and lung function in children
and in adults, few studies found an association between
indoor PM and lung function [1,24]. Vasomotor dys-
function, a predictor of cardiovascular events, has been
associated with exposure to ambient air PM and to high
concentrations of diesel exhaust particles in healthy
subjects, elderly, and susceptible groups [21-23,25,26].
Microvascular function (MVF) can be non-invasively
assessed as an index of vasomotor function by means of
Peripheral Arterial Tonometry (PAT), which is applic-
able in nonclinical settings such as private houses or of-
fices and has been shown predictive of cardiovascular
events in one study [27]. Short-term chamber exposure
studies with duration from 3-h to 24-h have not found a
significant association between exposure to ambient air
or wood smoke and MVF in young subjects, whereas 2
to 14 days with air filtration in homes decreased PM2.5
levels and improved MVF in middle-aged and elderly
subjects [28-30]. The PAT measurement also provides
baseline pulse amplitude that recently has been asso-
ciated with air pollution [31].
Systemic inflammation, which is regarded as an in-
termediate step from the respiratory particle exposure to
cardiovascular effects, has been assessed by biomarkers
including C-reactive protein (CRP) and counts of leuko-
cytes, especially neutrophils and other granulocytes [2,20].
Long- and short-term exposure studies, particularly with
children and healthy adults, show positive associations
between ambient PM and CRP, while there is less con-
sistency in associations with leukocytes and very limited
data for indoor air [32]. Indoor biomass smoke with high
PM concentrations was associated with increased CRP
levels in a cross-sectional study of Indian women [33].
One intervention study associated decrease in indoor par-
ticle exposure with decrease in CRP levels, whereas similar
studies found no effect on CRP [28,30,34].
Accurate individual exposure assessment in- and out-
side the home requires time-resolved personal monitoring.
Small portable instruments can measure PNC and per-
sonal exposure appears more strongly correlated to indoor
than ambient PNC levels [8,17,35]. However, the particles’
characteristics differ substantially in relation to the
sources, which can influence their potential toxicity.
Indeed, a personal monitoring study found ambient PNC,
mainly traffic derived, to be three times more potent in
oxidative stress-induced DNA damage in mononuclear
leukocytes than indoor PNC [36]. However, there is a lack
of knowledge on the difference in hazard between the
PNC exposure in home and out of home with respect to
vascular and lung function, as well as to inflammatory
responses.
The aim of the present study was to associate PNC con-
tinuously monitored through 48-h using a stationary
monitor in the home and a personal monitor worn both
in the home and away from home, with MVF, pulse ampli-
tude, blood pressure, lung function and biomarkers of in-
flammation among 60 healthy subjects and 23 spouses.
The hypothesis was that the exposure away from home
would be more strongly associated with the health-related
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outcomes than the exposure in the home, assessed by
portable and stationary instruments.
Methods
Study population
The study population was recruited from follow up of The
Health2006 cohort [37]. Participants of the Health2006
cohort consist of a random sample living in the South-
Western part of the greater Copenhagen area (a total
of 3471 persons with Danish citizenship and born in
Denmark) aged 18-69 years in 2006. The cohort was set
up for population-based research of prevalence and risk
factors of chronic diseases (coronary heart disease, dia-
betes, musculoskeletal disorders, chemical intolerance,
osteoporosis, asthma, allergy, chronic lung diseases and
mental disorders).
Inclusion criteria for the present study were no history
of smoking and residence at the same non-smoking ad-
dress for not less than the last six months. People taking
lipid lowering or vasoactive medication were excluded.
About 300 letters were sent by post to the eligible par-
ticipants of the cohort. Their healthy spouses were also
invited to participate. A total of 83 persons from 60 ad-
dresses (20% response) participated in the study. Two of
the subjects were excluded from the analyses of health-
related outcomes due to use of angiotensin II receptor
antagonist revealed after sample collection and recent
infection treated with antibiotics and resulting in a high
CRP level. The characteristics of the 81 participants with
health outcomes are presented in Table 1.
A written informed consent was obtained from each
participant. The study was reviewed and approved by The
Committees on Health Research Ethics in the Capital
Region of Denmark (file no. H-4-2012-173).
Exposure assessment
The study started on the 20th of February 2013 and was
finished on the 31st of May 2013. Exposure monitoring
for each home and person was performed during about
2 days. Seven Aerasense NanoTracer particle counters
(Philips) were used for both measurements (home mi-
croenvironment and personal monitoring) of PNC. Ac-
cording to the producer’s description the instrument
measures PNC for particles in 10 nm to 300 nm range
with 16 sec. time resolution.
All seven newly calibrated NanoTracers used in the ex-
periment were extensively tested against each other and
against a Scanning Mobility Particle Sizer (SMPS 3934,
TSI Inc., USA) in an aerosol chamber. The measurements
used for the comparison were performed over several days
during which cooking, candle, and incense burning events
took place. These chamber measurements also included
periods of low concentrations without sources present, in
order to represent concentrations occurring for example
in homes during unoccupied periods. The average
NanoTracer-to-SMPS concentration ratio varied between
0.69 and 1.22 for the seven instruments (average of all
instruments was 0.93) and this ratio was used as a correc-
tion factor for each instrument in order to compensate for
inter-equipment variation. The correction factors were
applied to the particle concentrations obtained from the
corresponding instruments, in order to obtain the final
results. A similar set of validation experiments with our
NanoTracer instruments have been described in detail
elsewhere [13], whereas further accuracy information is
available from other research groups [35]. The PNC ob-
tained from the instruments are considered a reasonably
proxy of UFP because particles larger than 100 nm gene-
rally contribute very little.
One NanoTracer along with a PM2.5 sampler (see
below) was placed in the living room. Average indoor
PNC from the monitoring in the homes was calculated
based on an average of 47-h data per home. An identical
NanoTracer was carried in a backpack by 59 participants
(one person from each home) for personal monitoring
throughout the time of the experiment including while be-
ing at home. The NanoTracer for personal monitoring
was connected to a sampling tube that was led outside of
the backpack. To optimize personal exposure monitoring,
the participants were asked to keep the backpack at their
bedside, while they were sleeping. On a few occasions the
personal monitor ran out of power before the end of the
measurement. The average PNC during the entire per-
sonal monitoring period (total personal PNC) was calcu-
lated from the available data, which corresponds to ≈ 43-h
Table 1 Characteristics of the study participants
(numbers or mean ± SD)
Men Women Total
Number 41 40 81
Age (years) 54 ± 12 49 ± 11 51 ± 12
Height (cm) 179 ± 7 167 ± 7 173 ± 9
Weight (kg) 79 ± 10 64 ± 10 72 ± 12
Body mass index (kg/m2) 25 ± 3 23 ± 3 24 ± 3
Hemoglobin (mmol/L) 10.8 ± 1.5 9.9 ± 1.5 10.4 ± 1.5
HbA1c (hemoglobin A1c; (mmol/mol) 37 ± 10.3 33.6 ± 4.0 35.3 ± 8.0
Glucose (mmol/L) 5.1 ± 11 4.7 ± 1.2 4.9 ± 1.2
Total cholesterol (mmol/L) 4.2 ± 0.9 4.1 ± 0.8 4.1 ± 0.8
LDL cholesterol (mmol/L) 2.6 ± 0.7 2.3 ± 0.7 2.4 ± 0.7
HDL cholesterol (mmol/L) 1.2 ± 0.3 1.6 ± 0.4 1.4 ± 0.4
Triglycerides (mmol/L) 1.0 ± 0.5 0.7 ± 0.3 0.9 ± 0.4
Personal monitoring
(number of participants)
36 23 59
Time spent away from home by
personal monitoring participants
during the experiment (%)
29 ± 14 29 ± 14 29 ± 14
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on average. Further, the integrated personal exposure was
calculated as PNC multiplied by time for the periods when
the person was at home (personal exposure at home) and
away from home (personal exposure away from home) ac-
cording to the information on occupancy times at home
from the individual diaries.
The indoor PM2.5 mass concentrations were measured
gravimetrically on Fluoropore Membrane PTFE filters
(37 mm; pore size, 1.0 μm; Millipore, Billerica, MA,
USA). The setup consisted of a cyclone sampling head
GK 2.05-KTL (BGI Inc, Waltham, MA, USA) with a cut
off diameter of 2.5 μm, a filter and a sampling pump.
The airflow through the sampling filter was adjusted to
4 L/min at the start of each measurement session and it
was checked again at the end of the measurement
period. Before and after sampling the filters were kept at
constant temperature (22°C) and relative humidity (50%)
for 24-h before being weighed. The average airflow was
used to calculate the average PM2.5 concentration in
each residence during the measurement period. In 8
homes the PM2.5 sampling was incomplete either due to
failure of the pump or because the pump was
intentionally stopped by the occupants disturbed by the
noise.
Assessment of health-related outcomes
On the third day of the experiment, after approximately
48-h of exposure monitoring and at around the same
time of day when the instruments were being unin-
stalled, the physiological function tests were performed
and material for biomarker analysis was collected.
Lung function: Spirometry test was performed using
the NDD Easy One Plus spirometer (ndd Medical
Technologies, Zurich Switzerland) in accordance with
the European Respiratory Society (ERS) standards and
American Thoracic Society (ATS) standards summarized
by Miller et al. [38]. The largest from at least three accept-
able manoeuvres of forced expiratory volume in the first
second (FEV1) and forced vital capacity (FVC) were re-
corded and used for calculation of the FEV1/FVC ratio.
Microvascular function (MVF): Prior to each MVF meas-
urement, resting blood pressure was measured by means
of a Welch Allyn DuraShock DS54 manometer (Welch
Allyn GmbH & Co. KG, Deutschland). The cuff was placed
above the elbow on one arm, which was afterwards used
for the occlusion in the MVF measurement. MVF was
measured by means of specially designed finger probes
(a pulse amplitude tonometry, EndoPAT device) placed on
the tip of index fingers of the subject (EndoPAT2000;
Itamar Medical Ltd, Cesaria, Israel) as described pre-
viously [28]. Baseline pulse amplitude measurements were
performed for 5 minutes, after which the blood pressure
cuff was inflated in order to stop blood flow through
the brachial artery, inducing ischemia in the test arm.
Occlusion of pulsatile arterial flow was confirmed by the
reduction of the PAT tracing to zero. After 5 minutes of
occlusion, the cuff was deflated, followed by reactive
hyperemia, and PAT measurements continued to be re-
corded for further 5 minutes. The MVF score was calcu-
lated by a computer algorithm automatically normalized
for the baseline PAT signal and for the signals of the
contralateral arm that served as a control.
Biomarkers in blood: On the day of the home visit, per-
ipheral venous blood samples were collected in EDTA
tubes. Within 4 hours after the draw, blood was analyzed
for hemoglobin, leukocytes and their subtypes, and sepa-
rated plasma was stored at -80°C for later CRP analysis at
the Department of Clinical Biochemistry, Copenhagen
University Hospital. Measurements of hemoglobin, leuko-
cytes lymphocytes, and monocytes counts, were performed
by an automatic portable hematological analyzer Chempaq
XBC (Chempaq A/S, Denmark), calibrated automatically
before each measurement. Neutrophils, eosinophil and ba-
sophil counts were measured by the HemoCue leukocyte
system (HemoCue AB, Sweden).
Statistical analysis
In order to assess the associations between individual
exposure and MVF, lung function, and inflammatory
markers, i.e. leukocytes, and CRP, multiple linear regres-
sion analysis was applied using the STATA 13 program
package (StataCorp LP, College Station, TX, USA). Re-
gression models were based on average personal PNC
during the whole measurement period or on the inte-
grated exposure, determined separately for the periods
when the subjects were in the home and away. Since the
subjects living at the same address share the measure of
exposure, which may violate the principle of predictor
variable independence between subjects, a generalized
estimating equations (GEE) model was used for PNC
and PM2.5 measured by the stationary indoor monitors.
For outcomes with more than one exposure metric as
significant predictor two-pollutant models were run. All
models were adjusted for possible confounders, i.e. sex,
age, and BMI, the latter two as continuous variables.
Results
A summary of the exposure data is presented in Table 2.
The subjects who carried a NanoTracer spent on aver-
age 29% of the time away from home. The personal aver-
age PNC over the total time of the experiment was more
strongly correlated with the average personal PNC when
away from home (r = 0.92) than with the average personal
PNC when at home (r = 0.37). The average personal PNC
when inside the home was significantly but modestly cor-
related with PNC (r = 0.41) and PM2.5 (r = 0.44) levels
measured by stationary monitors in the home during the
whole period. The personal exposure at home and away
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from home based on PNC and time spent at home and
away followed the same trends as for the corresponding
personal PNC.
Descriptive statistics for the health-related outcome var-
iables are presented in Table 3. The associations between
the health-related outcomes and the exposure levels esti-
mated as percent change per inter-quartile range (IQR)
are presented in Table 4. The associations were based on
57 subjects with personal monitoring data and 81 with
home monitoring data. Personal monitoring data for two
subjects were excluded from the analyses because of vaso-
active drug use and recent infection. PM2.5 data were
available for 72 subjects.
MVF was significantly inversely associated with the per-
sonal exposure away from home. Similar associations were
observed for the total personal PNC, but these results
were not significant. Pulse amplitude also showed signifi-
cant inverse association with personal exposure away from
home as well the total personal PNC. Significant positive
associations were found between total leukocyte and neu-
trophil counts and both total personal PNC and personal
exposure away from home. There was no such association
for the personal exposure at home. In two-pollutant
models including personal exposure at home and away
from home, all these significant associations with personal
exposure were retained (data not shown). Lung function
showed some inverse association with personal monito-
ring variables, although these were not statistically signifi-
cant. CRP and monocyte counts did not show significant
associations with any exposure metric.
Stationary indoor PNC and PM2.5 in the homes showed
statistically significant inverse association with eosinophil
counts. In a two-pollutant model only the association with
PM2.5 remained significant (data not shown). A similar,
but not significant, relationship was observed between
eosinophil counts and the personal monitoring variables.
Lymphocyte counts were positively associated with all ex-
posure variables, but the association was significant only
with respect to PM2.5 concentrations in the homes. The
stationary indoor PNC also showed significant positive
association with systolic and diastolic blood pressure.
These significant associations with PNC were retained in
a two-pollutant model including indoor PM2.5, which in
single-pollutant models showed borderline significant as-
sociations with blood pressure.
Discussion
The main findings of this cross-sectional study were that
personal exposure occurring away from home showed
inverse association with MVF as well as pulse amplitude
Table 2 Correlations between exposure variables
Personal monitoring - PNC Personal exposure Stationary indoor
(monitoring (home)
Total
period
(103/cm3)
While at
home
(103/cm3)
While away
from home
(103/cm3)
At home
(103/cm3)*h
Away from
home
(103/cm3)*h
PNC
(103/cm3)
PM2.5
(μg/m3)
N 59 59 59 59 59 81 72
Median (5th, 95th percentile) 9.2 8.3 8.8 285.9 125.9 8.4 12.2
(4.5, 36.5) (3.3, 36.7) (2.8, 55.5) (93.2, 1.041) (14.3, 927.8) (3.3, 23.0) (7.5, 24.1)
Personal
monitoring - PNC
Total 1.000
While at home 0.45* 1.000
(0.00)
While away from home 0.93* 0.10 1.000
(0.00) (0.43)
Personal exposure At home 0.37* 0.97* 0.02 1.000
(0.00) (0.00) (0.85)
Away from home 0.92* 0.09 0.99* −0.001 1.000
(0.00) (0.50) (0.00) (0.99)
Stationary indoor
monitoring
PNC 0.15 0.41* 0.01 0.36* 0.02 1.000
(0.24) (0.00) (0.94) (0.00) (0.86)
PM2.5 0.22 0.44* 0.03 0.38* 0.05 0.49* 1.000
(0.12) (0.00) (0.84) (0.00) (0.70) (0.00)
The variables include personal PNC (during total measurement period, while at home and while away from home), personal exposure occurring at home and
away from home, and stationary PNC and PM2.5 measured in the home.
Values are medians (5th, 95th percentiles) and Pearson product moment coefficients (p-values). * p < 0.05.
PNC: particle number concentration.
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and positive association with leukocyte and neutrophil
counts. Personal exposure at home and stationary PNC
inside the home did not show such associations, although
blood pressure was associated with stationary indoor
PNC. The results are consistent with the well-known
cardiovascular effects of traffic-generated UFP, which are
mainly encountered outside. The results suggest that par-
ticles from sources in the home might be less harmful.
There was no trend of inverse associations between
MVF and indoor stationary PNC or PM2.5 in our study,
although blood pressure did show association with station-
ary indoor PNC. Two indoor intervention studies with par-
ticle filtration over 2-7 days indicated improvement in
MVF measured with the EndoPat, but no effect on blood
pressure [29,30]. Although one of the studies measured
PNC levels in the home, it was reported that the particu-
late volume, which is closely related to mass concentration,
was a stronger predictor of the improved MVF than PNC.
In the other study, exposure was measured only in terms
of indoor PM2.5 mass concentration. Similarly, we have
Table 3 Microvascular function (MVF), pulse amplitude, blood pressure, lung function (FEV1/FVC), and biomarkers of
inflammation among 81 study participants
Biomarkers Total (n = 81) Men (n = 41) Women (n = 40)
MVF 1.9 (1.1, 3.1) 1.9 (1.1, 3.1) 1.9 (1.2, 3.4)
Log pulse amplitude 6.1 (4.3, 7.0) 6.4 (5.0, 7.0) 5.8 (4.2, 6.8)
Systolic blood pressure (mmHg) 120 (90, 150) 130 (110, 150) 120 (90, 140)
Diastolic blood pressure (mmHg) 70 (60, 90) 70 (60, 100) 70 (50, 85)
C-reactive protein (mg/L) 0.5 (0.1, 7.4) 0.5 (0.3, 7.5) 0.5 (0.1, 6.2)
Leukocytes (x109cells/L) 5.6 (3.3, 8.5) 5.2 (3.3, 8.5) 5.6 (3.5, 8.1)
Lymphocytes (x109cells/L) 1.7 (1.1, 2.6) 1.6 (1.0, 2.5) 1.7 (1.1, 3.2)
Monocytes (x109cells/L) 0.5 (0.2, 0.8) 0.5 (0.2, 0.7) 0.5 (0.2, 0.9)
Neutrophils (x109cells/L) 2.9 (1.6, 4.8) 2.8 (1.6, 5.6) 3.0 (1.7, 4.6)
Eosinophils (x109cells/L) 0.1 (0.0, 0.4) 0.1 (0.0, 0.4) 0.1 (0.0, 0.3)
FEV1/FVC 0.80 (0.7, 0.9) 0.80 (0.7, 0.9) 0.80 (0.7, 0.9)
Values are medians (5th, 95th percentiles). MVF, Microvascular function; FEV1, Forced expiratory volume 1s (L); FVC, Forced vital capacity (L).
Table 4 Associations between exposure and the health-related outcomes
Personal monitoring Stationary indoor monitoring (home)
PNC total period
(103/cm3)
Exposure at home
(103/cm3)*h
Exposure away from home
(103/cm3)*h
PNC
(103/cm3)
PM2.5_
(μg/m3)
Number of subjects N = 57 N = 57 N = 57 N = 81 N = 72
IQR 6.9 325.3 141.5 5.1 7.4
MVF −2.6 (-5.2, 0.1) 2.4 (-5.2, 10.5) −1.3* (-2.5, -0.1) −0.03 (-2.4, 2.4) 6.7 (-0.4, 14.3)
Baseline pulse amplitude −9.6* (-15.7, -3.0) −15.11 (-30.4, 3.6) −3.4* (-6.4, -0.3) −1.1 (-8.5, 7.0) −13.6 (-31.3, 8.6)
Systolic blood pressure 0.7 (-0.6, 2.0) 1.3 (-2.1, 4.8) 0.3 (-0.3, 0.8) 2.4* (0.9, 3.8) 4.6 (-0.003, 9.2)
Diastolic blood pressure 0.3 (-0.5, 1.2) 1.3 (-1.1, 3.7) 0.1 (-0.3, 0.5) 2.3* (1.4, 3.2) 2.8 (-0.4, 6.0)
C-reactive protein −1.2 (-11.7, 10.7) −3.1 (-28.5, 31.3) −0.5 (-5.3, 4.6) 6.1 (-2.2, 15.0) −4.8 (-14.8, 6.4)
Leukocytes 3.1* (0.3, 5.9) −0.7 (-7.9, 7.1) 1.5* (0.3, 2.7) 1.1 (-1.2, 3.5) 1.6 (-5.8, 9.5)
Lymphocytes 1.7 (-1.4, 5.0) 2.8 (-5.6, 11.9) 0.6 (-0.7, 2.1) 2.4 (-1.1, 6.0) 13.2* (1.3, 26.6)
Monocytes −0.8 (-4.6, 3.1) −6.4 (-15.6, 3.9) −0.03 (-1.7, 1.7) 1.4 (-3.5, 6.6) 5.8 (-7.6, 21.0)
Neutrophils 5.5* (1.7, 9.4) 1.9 (-8.3, 13.4) 2.4* (0.8, 4.1) 0.7 (-2.6, 4.1) −3.7 (-13.1, 6.6)
Eosinophils −3.3 (-8.6, 2.4) −9.0 (-23.6, 8.6) −1.0 (-3.4, 1.5) −5.2* (-9.8, -0.4) −16.3* (-27.1, -3.9)
FEV1/FVC −0.6 (-1.4, 0.2) −1.0 (-3.1, 1.2) −0.2 (-0.6, 1.1) 0.5 (-0.1, 1.1) 0.7 (-1.2, 2.6)
Percent change (95% confidence interval) in outcome levels associated with an interquartile range (IQR) increase in personal particle number concentration (PNC)
monitored for the whole period and personal exposure (concentration times time) at home and away from home estimated with regression models and with
stationary home indoor PNC and PM2.5 estimated with generalized estimation equations on the natural logarithm of the outcomes with adjustment for age,
gender, and BMI, respectively.
MVF, Microvascular function; FEV1, Forced expiratory volume 1s (L); FVC, Forced vital capacity (L). * p < 0.05.
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observed earlier that particle filtration in the home for 2
weeks was only associated with improvement in MVF in
relation to the actual decrease in PM2.5 in the bedroom
[28]. These intervention studies provided sufficient con-
trast in exposure to PM2.5 mass concentration and subjects
were staying at home most of the time whereas the cross-
over design limited the influence from potential inter-
individual confounders. A fourth intervention study with
one week indoor air filtration showed no effect on MVF,
which might be due to the young age of the study popula-
tion, tobacco smoke being the main source of PM in the
homes, and/or the use of electrostatic filters rather than
the high efficiency particulate adsorption filters, that were
used in the other intervention studies [39]. In addition, a
number of studies with young individuals found no effect
of short-term exposure to traffic and wood combustion
particles on MVF measured by EndoPat within a few hours
after exposure [34,40,41]. One study found an inverse asso-
ciation between MVF and ambient PM2.5 levels during the
two preceding days [40], whereas more recent studies
found no such associations [31,42]. Possibly, longer or
more intense exposure is required to detect the effects.
Although some of the personal exposure away from
home also occurred in indoor setting, the significant in-
verse association with MVF may support the notion of
deleterious effect of traffic- and diesel engine-generated
particles on endothelial function found in a number of
studies with controlled exposure at high levels [21,22].
This is further supported by our recent finding of in-
verse association between 48-h PNC in ambient air and
MVF in a cross-sectional study of citizens from central
Copenhagen [42], although another study with a much
wider catchment area in USA found no such association
[31]. The present finding of a parallel inverse association
between personal exposure away from home and pulse
amplitude suggests that vasoconstriction might play a
role, although the only study reporting this outcome in re-
lation to ambient air pollution found positive association
[31]. The highest dose intensity for PNC was encountered
for men during commuting in a personal exposure study
assessing time-activity patterns [35]. However, it should be
borne in mind that the period, indicated as “away from
home”, does not solely represent the time spent outdoors,
but also includes periods spent in other indoor envi-
ronments. Our findings indicate that there can be adverse
effects on MVF of exposure to relatively low number con-
centrations of UFP encountered in daily life away from
home (median of the 59 subjects’ average PNC: 8800 par-
ticles/cm3 of which >95% are UFP). This might be related
to systemic oxidative stress which has been indicated by
DNA base oxidation at similar UFP levels encountered
during commuting in Copenhagen, Denmark [36]. More-
over, the results also emphasize the power of combining
personal time-resolved exposure monitoring with a well-
established measure of a key function in vascular disease
employing non-invasive equipment applicable in field
studies.
Pulmonary and systemic inflammations are considered
to be important mechanisms in PM-induced cardiovas-
cular disease [2]. We found signs of an inflammatory re-
sponse in terms of increased total leukocyte and neutrophil
counts associated with the personal exposure away from
home, i.e. the same exposure metric associated with re-
duced MVF. No significant association between lung func-
tion and any exposure metric was observed. Short-term
effects of traffic-related UFP exposure on lung function
might be detectable mainly in susceptible adult subjects
with, for instance, asthma [43]. We have very recently in
another cross-sectional study performed in the winter
found that lung function and markers of systemic inflam-
mation were adversely associated with stationary PNC in
the home dominated by candle burning, whereas the
present study occurred in the spring with much less
candle burning [42]. Indoor UFP exposure also ap-
peared to be associated with inflammation and reduced
lung function in children [24]. Some panel studies of
risk groups showed associations between leukocyte
counts and PNC and/or PM2.5 [1,44,45], whereas con-
trolled exposures, including healthy subjects, did not
find such associations [25,26,46-48]. The statistically
significant inverse association between both PM2.5 and
PNC monitored in the home and eosinophil counts in the
blood could have occurred by chance but might also sug-
gest either lower allergen exposure or stronger allergen
tolerance associated with UFP exposure in the home [49],
which has also been shown in relation to smoking [50].
Most studies on associations between short-term expo-
sure to UFP or PM2.5 and CRP as a marker of inflam-
mation were conducted using ambient PM concentrations
measured at stationary monitoring stations, which is a
poor proxy for personal exposure [32]. However, earlier
studies with 24-h exposure to traffic derived UFP revealed
no significant association with CRP, which is consistent
with our findings [34,51]. Some studies report 1- to
28- days lag for CRP levels increase, while some long-term
studies revealed increase in CRP levels in highly exposed
populations [32].
Although stationary monitoring of indoor and ambient
particle concentrations can provide important informa-
tion, personal monitoring represents the most accurate
method to quantify individual exposure [8,17,35]. We
observed a high correlation between total personal PNC
during the whole measurement period and personal ex-
posure away from home, despite the fact that 70% of the
experiment time was spent in the home. It highlights the
importance of exposure away from home, which can
occur both outdoors and in various types of indoor envi-
ronments, including vehicles. The weaker correlations
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between total personal PNC and personal exposure at
home or the stationary indoor PNC in the living room,
suggest that UFP in the home contributed relatively little
to the total personal exposure in the present study. In-
deed, it supports the use of time-resolved personal mon-
itoring, although PNC measurements do not describe
chemical composition of particles, nor do they identify
sources of importance for health effects. For instance,
separate indoor and outdoor personal exposure to UFP
during 24-h periods in a panel study with 6 repeated
measurements with 14 subjects suggested that the out-
door particles were around three times more potent in
terms of increased levels of oxidative stress-induced
damage to DNA in leukocytes, compared to indoor par-
ticles [36]. Some chemical composition characteristics
such as the level of elemental carbon, polycyclic aro-
matic hydrocarbons or transition metals are typical for
traffic generated particles and can be measured in PM2.5
sampled on filters over a period of time, but without
time resolution. Indeed, the level of vanadium in per-
sonal PM2.5 filter samples were more closely related to
oxidatively damaged DNA in leukocytes than was the
total PM2.5 mass [52]. Individual differences in antioxi-
dant defenses may also explain differences in susceptibil-
ity to PM exposure and contribute to heterogeneity in
associations with outcomes [53].
The participants were people with no history of smok-
ing, living in non-smoking homes. Hence, the presence of
tobacco smoke, which is a major source of fine and ultra-
fine particles, was highly unlikely in the homes of the par-
ticipants. Thus, cooking and candle burning may have
been the main sources of UFP in the homes, although
penetration of ambient particles from outdoors could con-
tribute to indoor levels as well [8]. Indeed, in a recent
study, candle burning, which is popular during wintertime
in Denmark, was responsible on average for nearly 60% of
the residential daily integrated UFP exposure [13].
Our study has a number of limitations. We had no in-
formation on the activities of the participants during the
time they spent away from home. Such information
could allow us to further assess associations between
outcomes and specific exposures, such as those occur-
ring in traffic or in other environments with potentially
relevant sources. The cross-sectional design is suscep-
tible to confounding from individual risk factors, inclu-
ding those related to socioeconomic status, which was
not included in the analysis [54]. The associations be-
tween exposure and outcomes were relatively weak. We
tested multiple associations between exposures and out-
comes with inherent risk of chance findings. A larger
sample size would have increased the statistical power
and would allow adjustment for multiple testing and co-
variates. However, some of the outcomes in our data
could be related to the same mechanism of action, which
makes adjustment problematic. It is likely that the par-
ticipation rate of 20% among the invited homes provided
participants who were more concerned about their
health. Although some systematic selection bias is pos-
sible, this is not likely to severely limit the generalization
of the results.
Conclusion
The negative association between personal UFP exposure
away from home and MVF supports the hypothesis of
negative effects of ambient particle air pollution on car-
diovascular health, whereas indoor generated particles
might have smaller effects. The adverse effects could be
related to inflammation as suggested by a positive associ-
ation between personal exposure to UFP occurring away
from home and leukocyte and neutrophil counts. The re-
sults underline the benefit of using personal monitoring
for elucidating health effects of particles and warrant
future research with longer exposure monitoring, better
source characterization by detailed time-activity patterns,
chemical characterization, repeated outcome measure-
ments and considering seasonal variation.
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